These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 9603014)

  • 1. A ceramic system for delivering interleukin-2.
    Smith SW; Billotte WG; Krane D; Sage K; Bajpai PK
    Biomed Sci Instrum; 1997; 34():65-9. PubMed ID: 9603014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parameters of protein delivery using hydroxyapatite in simulated body fluid.
    Tscholl B; Billotte WG; Reed D; Smith S; Kreinbrink K; Bajpai PK
    Biomed Sci Instrum; 1997; 34():70-5. PubMed ID: 9603015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A hydroxyapatite system for the continuous release of coumadin an anticoagulant.
    Tarr ER; Lasserre A; Szmulowicz U; Bajpai PK
    Biomed Sci Instrum; 1997; 33():143-8. PubMed ID: 9731350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo dapsone release from hydroxyapatite reservoirs.
    Lasserre A; Berty S; Bajpai PK
    Biomed Sci Instrum; 1997; 33():149-54. PubMed ID: 9731351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxyapatite-oil composites for delivering AZT in simulated body fluid.
    Reed D; Billotte WG; Rush BJ; Odorzynski A; Kreinbrink K; Bajpai PK
    Biomed Sci Instrum; 1997; 34():59-64. PubMed ID: 9603013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a hydroxyapatite ceramic matrix for the continuous delivery of coumadin.
    Mileti IF; Bajpai PK
    Biomed Sci Instrum; 1995; 31():177-82. PubMed ID: 7654958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro delivery of dexamethasone using hydroxyapatite reservoirs.
    Billotte WG; Bajpai PK
    Biomed Sci Instrum; 1997; 34():13-7. PubMed ID: 9603005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a ceramic device for the continuous local delivery of steroids.
    Zafirau W; Parker D; Billotte W; Bajpai PK
    Biomed Sci Instrum; 1996; 32():63-70. PubMed ID: 8672691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxyapatite ceramics for continuous delivery of heparin.
    Abrams L; Bajpai PK
    Biomed Sci Instrum; 1994; 30():169-74. PubMed ID: 7948632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term sustained delivery of 3'-azido-2',3'-dideoxythymidine in vivo by means of HA and TCP delivery devices.
    Benghuzzi H
    Biomed Sci Instrum; 2000; 36():343-8. PubMed ID: 10834256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biocompatibility of steroid-HA delivery system using adult castrated rams as a model.
    Benghuzzi H; England B
    Biomed Sci Instrum; 2001; 37():275-80. PubMed ID: 11347402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioactive hydroxyapatite coatings on polymer composites for orthopedic implants.
    Auclair-Daigle C; Bureau MN; Legoux JG; Yahia L
    J Biomed Mater Res A; 2005 Jun; 73(4):398-408. PubMed ID: 15892136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled diffusional release of dispersed solute drugs from biodegradable implants of various geometries.
    Collins R; Paul Z; Reynolds DB; Short RF; Wasuwanich S
    Biomed Sci Instrum; 1997; 33():137-42. PubMed ID: 9731349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoprecursor cell response to strontium-containing hydroxyapatite ceramics.
    Xue W; Moore JL; Hosick HL; Bose S; Bandyopadhyay A; Lu WW; Cheung KM; Luk KD
    J Biomed Mater Res A; 2006 Dec; 79(4):804-14. PubMed ID: 16886220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biocompatibility of HA/TCP biphasic ceramics with co-cultured human osteoblasts in vitro].
    Lu X; Li S; Zhang J; Zhang Z; Lu B; Bu H; Li Y; Cheng J
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2001 Dec; 18(4):497-9. PubMed ID: 11791290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of hydroxyapatite particulate debris on the production of cytokines and proteases in human fibroblasts.
    Ninomiya JT; Struve JA; Stelloh CT; Toth JM; Crosby KE
    J Orthop Res; 2001 Jul; 19(4):621-8. PubMed ID: 11518271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous delivery of azidothymidine by hydroxyapatite or tricalcium phosphate ceramics.
    Cannon MR; Bajpai PK
    Biomed Sci Instrum; 1995; 31():159-64. PubMed ID: 7654955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Research development of hydroxyapatite-based composites used as hard tissue replacement].
    Ning C; Dai K
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2003 Sep; 20(3):550-4. PubMed ID: 14565037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of graded zirconia hydroxyapatite composite bioceramic and its immunocompatibility in vitro.
    Quan R; Yang D; Miao X; Wu X; Wang H; Li W
    J Biomater Appl; 2007 Sep; 22(2):123-44. PubMed ID: 17065164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of hydroxyapatite additive content on the bioactivity and biomechanical compatibility of bioactive nano-titania ceramics.
    Li Z; Qu Y; Yang B; Zhang B; Kim HM; Zhao H; Zhang X
    J Biomed Mater Res A; 2008 Aug; 86(2):333-8. PubMed ID: 17969021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.